MedPath

Talent Aortic Cuff Stent Graft System Compassionate Use Registry

Conditions
Abdominal Aortic Aneurysms
Registration Number
NCT00604643
Lead Sponsor
Medtronic Cardiovascular
Brief Summary

An evaluation of the TALENT Aortic Cuff in patients with existing AneuRx stent grafts who have experienced sub-optimal stent graft outcomes and are not deemed suitable candidates for treatment with an AneuRx Aortic Cuff.

Detailed Description

The primary purpose of this registry is to provide an endovascular means of treatment for those patients experiencing a sub-optimal outcome related to the implanted AneuRx bifurcated stent graft and who are not deemed suitable candidates for treatment with an AneuRx Aortic Cuff. A sub-optimal outcome is defined as either a Type I or Type III endoleak and/or an inadequate seal zone (\< 1 cm). For Registry purposes, a Type III endoleak will be defined as a proximal modular endoleak.

Recruitment & Eligibility

Status
NO_LONGER_AVAILABLE
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patient >= 18 years of age
  • Patient has a serious disease or condition
  • No generally acceptable alternative for treating patient is available
  • Patient has had the AneuRx stent graft system implanted >= 30 days
  • Patient has suboptimal outcome with the AneuRx stent graft system as evidenced by one or more of the following:
  • Type I endoleak
  • Type III endoleak (Proximal, modular)
  • Loss of seal zone
  • Proximal aortic neck diameter >= 14mm and <= 30mm
  • Angle between axis of the suprarenal aorta and aneurysm neck is <= 60 degrees
  • Patient is able and willing to be available for 12,24,26,48 and 60 months post-procedure
Exclusion Criteria
  • Patient is pregnant of lactating
  • Arterial access cannot be crossed with a delivery system
  • Excessive vessel tortuosity
  • Excessive aortic calcification
  • AneuRx stent graft system implanted within the last 30 days

Study & Design

Study Type
EXPANDED_ACCESS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (49)

Baptist Hospital

🇺🇸

Louisville, Kentucky, United States

Kaiser

🇺🇸

Oakland, California, United States

O'Connor Hospital

🇺🇸

San Jose, California, United States

Kaiser Hayward

🇺🇸

Union City, California, United States

Penrose Healthcare

🇺🇸

Colorado Springs, Colorado, United States

Hartford Hospital

🇺🇸

Hartford, Connecticut, United States

Washington Hospital

🇺🇸

Washington, District of Columbia, United States

Morton Plant Hospital

🇺🇸

Clearwater, Florida, United States

North Florida Regional Medical Center

🇺🇸

Gainesville, Florida, United States

University of Florida

🇺🇸

Gainesville, Florida, United States

Scroll for more (39 remaining)
Baptist Hospital
🇺🇸Louisville, Kentucky, United States
© Copyright 2025. All Rights Reserved by MedPath